Recently, an article published in ChicagoInno describes how Tempus is partnering up with University of Chicago Medicine to analyze data that will help patients suffering from breast-cancer. This data, used from DNA sequencing, will help doctors better treat patients, through gathering more accurate data that can be used during treatment. This will hopefully make treatments more effective and comfortable for those who are battling breast cancer, through machine learning.
You can find the article here:
Tempus is a machine learning company, based in Chicago. The company is proud to boast its collection of molecular data, using genomic sequencing. Their overall aim is to improve patient treatment outcomes. Tempus partners up with physicians to use previous data to make new outcomes for patients who are currently undergoing treatment. Tempus understands the genetic process in cancer growth, and with this knowledge, they help patients understand how to best battle their cancer and more information click here.
Eric Lefkofsky is the co-founder and CEO of Tempus. Born in Michigan in 1969, Eric has had a successful career, and has positively impacted the lives of people who are in the fight of their lives. He is the son of a teacher and a structural engineer, and he has a brother and sister. Graduating from South Lathrup High School in 1987, Eric went on to the University of Michigan Law School to receive a J.D. degree in 1991.
With a background in law, Eric went on to pursue many entrepreneurial ventures, from selling clothing to logistics. In addition to his entrepreneurial career, Eric is a philanthropist, teacher and writer and what Eric knows.
Fun fact: Eric is also the co-founder of Groupon, which isn’t a shook considering his innovative abilities. He also was one of the people to help bring the summer olympics to Chicago.